High-energy inositol pyrophosphates, such as IP7 (diphosphoinositol pentakisphosphate), can directly donate a -phosphate to a prephosphorylated serine residue generating pyrophosphorylated proteins. Here, we show that the  subunit of AP-3, a clathrin-associated protein complex required for HIV-1 release, is a target of IP 7-mediated pyrophosphorylation. We have identified Kif3A, a motor protein of the kinesin superfamily, as an AP3B1-binding partner and demonstrate that Kif3A, like the AP-3 complex, is involved in an intracellular process required for HIV-1 Gag release. Importantly, IP 7-mediated pyrophosphorylation of AP3B1 modulates the interaction with Kif3A and, as a consequence, affects the release of HIV-1 virus-like particles. This study identifies a cellular process that is regulated by IP 7-mediated pyrophosphorylation.phosphorylation ͉ trafficking ͉ kinesin I nositol pyrophosphates such as IP 7 (diphosphoinositol pentakisphosphate or PP-IP 5 ) belong to a class of inositol polyphosphates containing highly energetic pyrophosphate moieties that undergo very rapid turnover (1, 2). Inositol pyrophosphates have been implicated in numerous important cellular events (3, 4), including apoptosis (5, 6) and insulin secretion (7,8), and the use of radiolabeled IP 7 (5[ 32 P]IP 7 ) has allowed us to demonstrate that the high-energy pyrophosphate bond can participate in phospho-transfer reactions (9). One of the hallmarks of protein phosphorylation via IP 7 is that the putative targets contain a serine-rich acidic region (9). IP 7 substrates must initially be primed through ATP-dependent protein kinase phosphorylation (10), following which the phospho-serine becomes a substrate of IP 7 -mediated pyrophosphorylation (10). However, the physiological in vivo significance of this posttranslational modification remains unclear. To address the functional significance of protein pyrophosphorylation, we investigate the effect of this posttranslational modification in the functionality of the adaptor protein complex AP-3. ResultsThe  subunit of the adaptor protein complex AP-3 (AP3B1) (Fig. 1A) was initially identified as a potential target for IP 7 phosphorylation by database searching for proteins containing serine-rich acidic regions. Adaptor protein complexes, comprising AP-1 to AP-4, mediate the sorting of transmembrane and cargo proteins to specific membrane compartments within the cell (11, 12). The AP-3 complex in particular is involved in sorting to lysosomes and related organelles (13,14). It contains two large subunits ( and ␦), a medium subunit ( 3 ), and a small subunit ( 3 ) (12). The AP3B1 subunit contains three main domains: the N-terminal head domain, the hinge, and the C-terminal ear domain ( Fig. 1 A and Fig. S1 A). The putative target region of IP 7 phosphorylation lies within the hinge domain, which contains three distinct serine-rich acidic stretches that we named regions I, II, and III ( Fig. 1 A and Fig. S1 A). To test whether human AP3B1 is a substrate of IP 7 -mediated phosphorylation, we per...
Following fertilization, gametes undergo epigenetic reprogramming in order to revert to a totipotent state. How embryonic cells subsequently acquire their fate and the role of chromatin dynamics in this process are unknown. Genetic and experimental embryology approaches have identified some of the players and morphological changes that are involved in early mammalian development, but the exact events underlying cell fate allocation in single embryonic cells have remained elusive. Experimental and technological advances have recently provided novel insights into chromatin dynamics and nuclear architecture in single cells; these insights have reshaped our understanding of the mechanisms underlying cell fate allocation and plasticity in early mammalian development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.